Accelerating Regenerative Medicine

Follow RegMed XB on LinkedIn

Valorization Voucher – Learn more

  • Upcoming events

    Annual2025

    Annual Conference 2026

    Be part of the 4th RegMed XB Annual Conference: Collaborate to Regenerate. Get inspired and expand your network within the regenerative medicine field.

     read more

  • Expertise

    Business Development & Valorization

    Accelerating Innovation in Regenerative Medicine

     read more

    Research Excellence: Moonshots

    Push the boundaries of research excellence

     read more

    Infrastructure: RegMed XB's Pilot Factory

    A seamless pathway for innovators to accelerate, de-risk, and scale regenerative therapies

     read more

    Public-Private Entrepreneurship

    Building ecosystems through collaboration

     read more

    Seed Capital

    Secure early-stage funding

     read more

  • Latest news

    Reumaweek

    Healing Damaged Joints with Regenerative Medicine

    Within the RegMed XB consortium, researchers are developing solutions to repair joint defects, primarily in the knee, through regenerative medicine. These efforts are carried out within the Osteoarthritis (OA) Moonshot and supported by the broader infrastructure of the RegMed XB Pilot Factory, one of the largest international infrastructures for regenerative medicine.

     read more
    ICAT 400x400

    ICAT strengthens RegMed XB Pilot Factory with new location at Plus Ultra Utrecht

    The Innovation Center for Advanced Therapies (ICAT), part of UMC Utrecht, has moved into Plus Ultra Utrecht at Utrecht Science Park. This step strengthens the regional infrastructure for regenerative medicine and supports the activities of the RegMed XB Pilot Factory.

     read more
    TTT logo's

    BGV announces the close of the FIRST II fund to accelerate Dutch life science spinouts in chronic diseases

    BioGeneration Ventures (BGV) has announced the close of FIRST II (Fonds InvesteringsRijpe Starters), reaching 12 million euro to support the creation and development of early-stage life sciences start-ups emerging from Dutch academic research.

     read more

  • Moonshots (research excellence)

    Cardiovascular Moonshot

    Regeneration of the human heart

     read more

    Diabetes Moonshot

    A proof-of-concept therapy for Type 1 Diabetes

     read more

    Kidney Moonshot

    The first subunit of a bio-engineered kidney

     read more

    Osteoarthritis Moonshot

    The road to a bio-artificial joint

     read more

  • Pilot Factory (infrastructure)

    The RegMed XB Pilot Factory is one of the largest international infrastructures for regenerative medicine. It brings together all the expertise and infrastructure needed to bring regenerative medicine to the market.

    → Pilot Factory

  • RegMed XB's Ecosystem

    Health Foundations

    The following Dutch health foundations are involved in defining research objectives and provide guidance in the research we conduct to ensure we maintain focus on the patient.

     read more

    Academic Partners

    RegMed XB works together with (inter)national top-rated academic institutions and collaborates specifically and exclusively with researchers who contribute specific expertise to the Moonshot initiatives.

     read more

    Industrial Partners

    Partnering with companies offers access to their expertise in designing scalable and feasible products. Currently, we have strong partnerships with the following entities.

     read more

    Governmental Partners

    RegMed XB receives support from national and local governments to de-risk promising concepts from academia to proof of concept or initial clinical trial stages.

     read more

    Life Science & Health partners

    The following Life Science & Health (LSH) partners are collaborate with RegMed XB.

     read more